positive half yearly out

I like the positive feel of the report....

Looks like phase 1 trials are on track...ready for reporting in the 2nd quarter.....

Looking forward into 2007/08 looks like it will be interesting times.

Likely Developments
In the 2007/2008 financial years, Dia-B expects to:
• Commence a Phase 2 human clinical trial for ISF402;
• Apply for Ausindustry grant assistance for the Phase 2 trial of ISF402;
• Undertake significant negotiations with interested pharmaceutical companies for the ISF402 peptide;
• Progress the provisional patent applications previously lodged for the new discovery of action whereby ISF402
interacts with zinc ions, and the major discovery re the mechanism of the dispersal of insulin into a fast-acting form;
• Progress and critically evaluate all other projects;
• Examine other business and project opportunities.